首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   561篇
  免费   60篇
  国内免费   111篇
  2023年   15篇
  2022年   21篇
  2021年   40篇
  2020年   42篇
  2019年   47篇
  2018年   49篇
  2017年   50篇
  2016年   42篇
  2015年   21篇
  2014年   44篇
  2013年   89篇
  2012年   35篇
  2011年   12篇
  2010年   12篇
  2009年   16篇
  2008年   18篇
  2007年   12篇
  2006年   27篇
  2005年   21篇
  2004年   18篇
  2003年   18篇
  2002年   12篇
  2001年   8篇
  2000年   7篇
  1999年   8篇
  1998年   11篇
  1997年   11篇
  1996年   8篇
  1995年   3篇
  1994年   1篇
  1993年   2篇
  1992年   4篇
  1991年   2篇
  1990年   1篇
  1989年   1篇
  1983年   1篇
  1978年   2篇
  1976年   1篇
排序方式: 共有732条查询结果,搜索用时 0 毫秒
731.
ABSTRACT

The international landscape of medical research is in the midst of a process of diversification and change. The randomized controlled trial (RCT), long considered the global gold standard for clinical research, has become increasingly contested and is partly replaced by alternative methodologies, standards and forms of evidence. The contours of mainstream medical research are changing as a result. Regulatory paradigms and standards are, literally, being rewritten, at a global level. The evidence-based medicine (EBM) hierarchy of evidence is redefined. This special issue explores these developments through the concept of ‘alter-standardization’. The term refers to the processes, controversies and negotiations through which multiphase RCTs and the EBM system are challenged and gradually superseded by alternative methodological and regulatory forms and standards. This special issue examines the conceptual, practical and theoretical implications of these changes, and the ways in which these transformations influence the situation and possibilities of patients, knowledge producers, physicians, large pharmaceutical corporations, smaller biotech companies, as well as regulatory bodies, civil societal organizations and national health care systems. The articles in this special issue make use of comparative and historical perspectives that focus on scientific, social, economic and regulatory developments in the European Union, China, India, Japan, Argentina, the UK and the USA. They show that the alter-standardizing of clinical trials arises in a pluralistic way, that is driven by a variety of often conflicting factors, developments and expectations. These changes reflect a broad transformation in the culture and politics of biomedicine today, with implications for the ways in which new medicinal products, devices, procedures and technologies are developed, approved for clinical use, sold to consumers, and licensed by health care systems.  相似文献   
732.
Because of growing population and a consequent increase in number of vehicles, the problem of parking personal vehicles is becoming explosive. This paper suggests efficient use of surplus space to be utilized as parking slot using analytical hierarchy process and integer programming model. Examples covering a real situation justify the approach. Copyright © 2011 John Wiley & Sons, Ltd.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号